231 related articles for article (PubMed ID: 37133922)
1. Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation.
Joshi S; Verma R; Lathia T; Selvan C; Tanna S; Saraf A; Tiwaskar M; Modi A; Kalra S; K V; Chitale M; Malde F; Abdul Khader M; Singal AK
JMIR Diabetes; 2023 May; 8():e43292. PubMed ID: 37133922
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data.
Krishnakumar A; Verma R; Chawla R; Sosale A; Saboo B; Joshi S; Shaikh M; Shah A; Kolwankar S; Mattoo V
J Med Internet Res; 2021 Mar; 23(3):e17908. PubMed ID: 33764306
[TBL] [Abstract][Full Text] [Related]
3. Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.
Kumbara AB; Iyer AK; Green CR; Jepson LH; Leone K; Layne JE; Shomali M
JMIR Diabetes; 2023 Sep; 8():e47638. PubMed ID: 37590491
[TBL] [Abstract][Full Text] [Related]
4. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
[TBL] [Abstract][Full Text] [Related]
5. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study.
Oser TK; Cucuzzella M; Stasinopoulos M; Moncrief M; McCall A; Cox DJ
JMIR Diabetes; 2022 Feb; 7(1):e34465. PubMed ID: 35050857
[TBL] [Abstract][Full Text] [Related]
6. Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study.
Berman MA; Guthrie NL; Edwards KL; Appelbaum KJ; Njike VY; Eisenberg DM; Katz DL
JMIR Diabetes; 2018 Feb; 3(1):e4. PubMed ID: 30291074
[TBL] [Abstract][Full Text] [Related]
7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of a Digital Therapeutic Intervention in Indian Patients With Type 2 Diabetes Mellitus: 12-Week Prospective Single-Arm Intervention Study.
Chawla R; Jaggi S; Gupta A; Bantwal G; Patil S
JMIR Diabetes; 2022 Oct; 7(4):e41401. PubMed ID: 36226840
[TBL] [Abstract][Full Text] [Related]
10. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Digital Health Tools for Diabetes Self-Management in Hispanic Adults: Exploratory Study.
Yingling L; Allen NA; Litchman ML; Colicchio V; Gibson BS
JMIR Diabetes; 2019 Jul; 4(3):e12936. PubMed ID: 31313657
[TBL] [Abstract][Full Text] [Related]
12. Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study.
Zimmermann G; Venkatesan A; Rawlings K; Scahill MD
JMIR Diabetes; 2021 Jun; 6(2):e28033. PubMed ID: 34075880
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Baseline Hemoglobin A1c on Digital Health Coaching Outcomes in Adults With Type 2 Diabetes: Real-World Retrospective Cohort Study.
Martin M; Patterson J; Allison M; O'Connor BB; Patel D
JMIR Diabetes; 2021 Jun; 6(2):e24981. PubMed ID: 34010804
[TBL] [Abstract][Full Text] [Related]
14. A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study.
Koot D; Goh PSC; Lim RSM; Tian Y; Yau TY; Tan NC; Finkelstein EA
JMIR Mhealth Uhealth; 2019 May; 7(5):e12965. PubMed ID: 31127720
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Continuous Usage of a Diabetes Management App on Glycemic Control in Real-world Clinical Practice: Retrospective Analysis.
Tu YZ; Chang YT; Chiou HY; Lai K
J Med Internet Res; 2021 Jul; 23(7):e23227. PubMed ID: 34264192
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Low Carb Program Digital Intervention for the Self-Management of Type 2 Diabetes and Prediabetes in an NHS England General Practice: Single-Arm Prospective Study.
Summers C; Tobin S; Unwin D
JMIR Diabetes; 2021 Sep; 6(3):e25751. PubMed ID: 34499035
[TBL] [Abstract][Full Text] [Related]
17. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days.
Verma R; Bhardwaj S; Lathia T; Kalra S; Ranadive R; Tanna S; Padsalge M; Juneja A; Samundra K; Thakkar PB; Jain V; Kini V; Kothari S; Guntur S; Joshi S; Singal A
Int J Diabetes Dev Ctries; 2023 Jun; 43(3):425-432. PubMed ID: 35892065
[TBL] [Abstract][Full Text] [Related]
18. Association Between Mobile Health App Engagement and Weight Loss and Glycemic Control in Adults With Type 2 Diabetes and Prediabetes (D'LITE Study): Prospective Cohort Study.
Lim SL; Tay MHJ; Ong KW; Johal J; Yap QV; Chan YH; Yeo GKN; Khoo CM; Yaxley A
JMIR Diabetes; 2022 Sep; 7(3):e35039. PubMed ID: 36178718
[TBL] [Abstract][Full Text] [Related]
19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
20. User Engagement, Acceptability, and Clinical Markers in a Digital Health Program for Nonalcoholic Fatty Liver Disease: Prospective, Single-Arm Feasibility Study.
Björnsdottir S; Ulfsdottir H; Gudmundsson EF; Sveinsdottir K; Isberg AP; Dobies B; Akerlie Magnusdottir GE; Gunnarsdottir T; Karlsdottir T; Bjornsdottir G; Sigurdsson S; Oddsson S; Gudnason V
JMIR Cardio; 2024 Feb; 8():e52576. PubMed ID: 38152892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
